Elevation of inactive cleaved annexin A1 in the neocortex is associated with amyloid, inflammatory and apoptotic markers in neurodegenerative dementias
- PMID: 34861326
- DOI: 10.1016/j.neuint.2021.105251
Elevation of inactive cleaved annexin A1 in the neocortex is associated with amyloid, inflammatory and apoptotic markers in neurodegenerative dementias
Abstract
Inflammation is usually a tightly regulated process whose termination by mediators including Annexin A1 (AnxA1) results in the resolution of inflammatory responses. In neurodegenerative dementias, chronic neuroinflammation, along with accumulation of aggregated β-amyloid (Aβ) peptides and apoptosis, has long been recognized to be a pathological hallmark; but it is unclear whether a failure of inflammation resolution contributes to this pathophysiological process. In this study, we measured AnxA1 immunoreactivities in postmortem neocortex (Brodmann areas BA9 and BA40) of well characterized Alzheimer's disease (AD), Parkinson disease dementia (PDD) and dementia with Lewy bodies (DLB) patients as well as aged controls. Inactive cleaved AnxA1 was found to be elevated in AD and DLB in BA40. Levels of cleaved AnxA1 also positively correlated with amyloidogenic brain Aβ, anti-inflammatory markers such as IL10 and IL13, as well as with the pro-apoptotic marker cleaved caspase-3 in BA40. Our findings suggest that elevated cleaved AnxA1 in neurodegenerative dementias may reflect a failure of inflammation resolution in certain regions of the diseased brain, and also support a mechanistic link between AnxA1 and amyloid pathology, neuroinflammation and apoptosis.
Keywords: Alzheimer's disease; Annexin A1; Apoptosis; Dementia with lewy bodies; Neuroinflammation; Parkinson's disease dementia.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Similar articles
-
Inflammatory panel cytokines are elevated in the neocortex of late-stage Alzheimer's disease but not Lewy body dementias.J Neuroinflammation. 2023 May 8;20(1):111. doi: 10.1186/s12974-023-02789-8. J Neuroinflammation. 2023. PMID: 37158957 Free PMC article.
-
The anti-inflammatory Annexin A1 induces the clearance and degradation of the amyloid-β peptide.J Neuroinflammation. 2016 Sep 2;13(1):234. doi: 10.1186/s12974-016-0692-6. J Neuroinflammation. 2016. PMID: 27590054 Free PMC article.
-
Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration.Brain Pathol. 2019 Jan;29(1):63-74. doi: 10.1111/bpa.12631. Epub 2018 Oct 17. Brain Pathol. 2019. PMID: 30051532 Free PMC article.
-
[Pathological and clinical comparison of Parkinson’s disease dementia and dementia with Lewy bodies].Orv Hetil. 2020 May 1;161(18):727-737. doi: 10.1556/650.2020.31715. Orv Hetil. 2020. PMID: 32338488 Review. Hungarian.
-
Imaging the role of amyloid in PD dementia and dementia with Lewy bodies.Curr Neurol Neurosci Rep. 2014 Aug;14(8):472. doi: 10.1007/s11910-014-0472-6. Curr Neurol Neurosci Rep. 2014. PMID: 25011528 Review.
Cited by
-
Truncated Tau caused by intron retention is enriched in Alzheimer's disease cortex and exhibits altered biochemical properties.Proc Natl Acad Sci U S A. 2022 Sep 13;119(37):e2204179119. doi: 10.1073/pnas.2204179119. Epub 2022 Sep 6. Proc Natl Acad Sci U S A. 2022. PMID: 36067305 Free PMC article.
-
Surface protein profiling and subtyping of extracellular vesicles in body fluids reveals non-CSF biomarkers of Alzheimer's disease.J Extracell Vesicles. 2024 Apr;13(4):e12432. doi: 10.1002/jev2.12432. J Extracell Vesicles. 2024. PMID: 38602321 Free PMC article.
-
Investigation of Inflammation in Lewy Body Dementia: A Systematic Scoping Review.Int J Mol Sci. 2023 Jul 28;24(15):12116. doi: 10.3390/ijms241512116. Int J Mol Sci. 2023. PMID: 37569491 Free PMC article.
-
Human amygdala involvement in Alzheimer's disease revealed by stereological and dia-PASEF analysis.Brain Pathol. 2023 Sep;33(5):e13180. doi: 10.1111/bpa.13180. Epub 2023 Jun 18. Brain Pathol. 2023. PMID: 37331354 Free PMC article.
-
Leveraging Plasma Membrane Repair Therapeutics for Treating Neurodegenerative Diseases.Cells. 2023 Jun 18;12(12):1660. doi: 10.3390/cells12121660. Cells. 2023. PMID: 37371130 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous